Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Surviving VA Slashes: Home Care Providers Report Rate Cut Impacts
In November, the U.S. Department of Veterans Affairs slashed reimbursement rates for home health aide and homemaker services, cutting Texas rates by 43% and New Mexico rates by 19%. The reductions have forced providers like Live Well Home Care to stretch staff, delay start‑of‑care, and absorb financial losses, while others such as Synergy HomeCare have leveraged their broader footprint to grow market share despite lower pay. Providers report veterans in rural areas facing reduced access, and industry groups are lobbying the VA to restore 2025 rates. The cuts also follow earlier VA limits on care hours, which have pushed more veterans into higher‑cost settings.
Word Games: How Moderna Is Selling Its Newest Vaccine without Using the “V” Word
Moderna’s $776 million federal award for a bird‑flu vaccine is under scrutiny after U.S. officials targeted mRNA technology, prompting the company to warn it may halt late‑stage vaccine programs. Simultaneously, Moderna and Merck are advancing an mRNA‑based cancer treatment, which Merck...
Viewpoint: Health Experts Engage MAHA: Shared Concerns, Differing Views on What Constitutes Evidence
At a national public‑health meeting, MAHA leaders joined physicians and public‑health professionals for a rare, good‑faith dialogue about evidence and communication. The MAHA speakers relied heavily on storytelling, while the health experts emphasized data‑driven logic. The discussion highlighted that effective...
Which Colorectal Cancer Screening Method Is Right for You?
Colorectal cancer screening saves lives, with colonoscopy remaining the gold‑standard due to its 70% detection rate and ability to remove polyps during the exam. Alternative methods include virtual colonoscopy, flexible sigmoidoscopy, stool‑based FIT/DNA tests, and the newly FDA‑approved Shield™ blood...
Why We Need to Ease the Path to Post-Prison Health Care
Every year roughly 600,000 Americans leave prison, and the majority qualify for Medicaid, a critical lifeline for chronic health needs and family stability. Starting Jan. 1 2027, Medicaid will impose nationwide work requirements, giving newly released individuals only 90 days to log...
DOJ Reclassifies Medical Marijuana to Schedule III: Key Implications for Florida and National Cannabis Operators
The U.S. Department of Justice has reclassified state‑licensed medical marijuana from Schedule I to Schedule III, the most significant federal cannabis reform in five decades. The change applies only to FDA‑approved cannabis products and state‑run medical programs, leaving adult‑use and illicit markets...
Low‑Quality Studies Mislead Clinical Decisions, Women Deserve Better
I said what I said. Telling people that methodologically low quality studies are important work for clinical decisions is not science. They may reinforce someone’s pet and financially profitable hypothesis. there’s a big problem in medicine or people put out...
The Antitrust Scrutiny Continues: FTC Launches New Healthcare Task Force
On April 28, 2026 the Federal Trade Commission announced a new Healthcare Task Force designed to unify its Competition, Consumer Protection, Economics, Planning and Technology bureaus. The task force will focus on antitrust risks in health‑care consolidation, pricing practices and...
What Are Peptides And Why Is Everyone Talking About Them?
Peptide therapies, short chains of amino acids that act like hormones, have surged in popularity as wellness supplements promising vitality and longevity. The most clinically vetted peptide, GLP‑1, is now used by roughly 10 million Americans for obesity and appetite control,...
The Secretary Of Health & Human Services Doesn’t Believe In The Foundation Of Modern Medicine
Robert F. Kennedy Jr. publicly denied the germ theory of disease during a Senate hearing on the measles outbreak, prompting sharp rebuke from Senators Bernie Sanders and Bill Cassidy. Kennedy cited outdated studies to argue that sanitation, not vaccines, reduced...
Swept-Source Optical Coherence Tomography Angiography May Predict Diabetic Nephropathy
A Harvard‑based study published in the July issue of the American Journal of Ophthalmology shows that swept‑source optical coherence tomography angiography (OCTA) can serve as a non‑invasive biomarker for diabetic nephropathy. Researchers analyzed 375 eyes from 234 diabetic patients and...
CRL Release Update – No Litigation War yet, but New Citizen Petition Beats the Drums
The FDA has begun posting Complete Response Letters (CRLs) for unapproved NDAs, ANDAs, and BLAs, releasing 127 documents to date, including 36 that had never been publicly disclosed. A Washington‑based law firm filed a Citizen Petition on April 20, 2026,...
Why Are Americans in One Region Dying Years Earlier Than Rest of Country?
A recent analysis highlights that residents of several Southern states—Mississippi, Louisiana, Alabama, South Carolina, Kentucky, Arkansas and Tennessee—die 5‑10 years earlier than the national average. The gap is linked to higher rates of chronic diseases, rural hospital closures, limited preventive...
Jazz Pharma’s Ziihera Combos Get FDA Priority Review for First‑line HER2‑positive Gastric Cancer
Jazz Pharmaceuticals announced that the FDA has accepted its supplemental Biologics License Application for Ziihera (zanidatamab‑hrii) combinations and placed the filing under priority review. The decision sets a PDUFA target action date of August 25, 2026, and follows breakthrough‑therapy designation...
House Committee Challenges Hospital CEOs Over Rising Costs, Citing Consolidation
House Ways and Means Chairman Jason Smith grilled CEOs of HCA Healthcare, CommonSpirit Health, New York‑Presbyterian and others, accusing hospitals of “insane” pricing and consolidation that inflates costs. Lawmakers and hospital leaders clashed over who bears responsibility for the nation’s...
Eli Lilly Inks AI Partnership with Profluent, Eyeing $2.25 B in Gene‑editing Milestones
Eli Lilly announced a collaboration with AI‑focused biotech Profluent to create advanced gene‑editing tools that could insert whole genes. The agreement may trigger $2.25 billion in milestone payments, highlighting Lilly’s rapid expansion into genetic medicines.
Sanofi Appoints Belén Garijo as CEO, Vows to Curb $18.4 Bn Dupixent Reliance
Sanofi announced Belén Garijo will assume the chief‑executive role on April 29, inheriting a business where Dupixent generates $18.4 bn in annual revenue. Garijo’s mandate includes leveraging a $30 bn M&A war chest to broaden the pipeline before Dupixent’s 2031 patent expiry.
Independent, Academic Cancer Trials Are Vital to Improve Patient Outcomes Worldwide
A Lancet Oncology Commission has been launched to evaluate the role of independent, academic cancer trials worldwide. The initiative stems from a coalition of 35 investigators and patient advocates spanning six continents, coordinated by the European Organisation for Research and...
Patients Treated for Common Cancers in Community Settings Live Longer, COA Study Finds
A COA‑commissioned study using Flatiron Health and SEER data shows patients with metastatic breast cancer and metastatic NSCLC treated in community oncology practices have longer overall survival than national benchmarks. Median survival for metastatic breast cancer was 48 months versus...
AAP Calls for Equal Priority of Children’s Mental and Physical Health in New Report
The American Academy of Pediatrics issued a clinical report urging pediatricians to give mental and emotional health the same priority as physical health. The guidance, released ahead of Mental Health Awareness Month, calls for a biopsychosocial model and outlines barriers...
Dietitians Stress Nutrition Counseling Is Key to GLP‑1 Weight‑loss Success
Registered dietitian Grace Derocha warned that without professional nutrition guidance, the surge in GLP‑1 use—now reported by 12.4% of U.S. adults—could lead to suboptimal or unsafe weight‑loss outcomes. She estimates 30‑50% of her clients are on or considering GLP‑1 therapy,...
Novartis' Rhapsido Wins EU Approval as First Oral Treatment for Chronic Spontaneous Urticaria
Novartis' oral BTK inhibitor Rhapsido (remibrutinib) has secured European Commission approval, marking the first oral targeted therapy for chronic spontaneous urticaria (CSU) in the EU. The decision follows a positive CHMP opinion in February 2026 and opens a new market...
Johnson & Johnson Halves Drug Lead‑optimization Time with AI
Johnson & Johnson announced that its artificial‑intelligence platform has reduced the time required to generate drug‑development leads by half. CIO Jim Swanson highlighted accelerated progress on an oncology and an immunology compound, underscoring AI’s growing role in pharma R&D.
Longevity and AI Lead Disruptive Tech Conversation at BofA
The annual Bank of America event on disruptive technologies was amazing and insightful as usual. Key technologies were Longevity and AI drug discovery (what I care about the most), Brain-Compute Interfaces (I also care about it very much), Space, Electric...
AI Detects Hidden Pancreatic Cancer at 73% Accuracy
An AI that detects occult pancreatic cancer better than radiologists (73 vs 39%) via CT with external validation https://t.co/NIiIFjlyxp https://t.co/8aVAmy0eFl
FTC Settlement Compels Express Scripts to Offer Cheaper Insulin Options
The Federal Trade Commission reached a settlement with Cigna's Express Scripts, the first of three major pharmacy benefit managers to be sued over insulin pricing. The agreement obligates the PBM to place the lowest‑cost drug on patients' formularies, though it...
Lovelace AI Launches Elemental Context Engine for Mission‑Critical Enterprise Use
Lovelace AI emerged from stealth today, introducing Elemental—a context‑engine platform that builds secure knowledge graphs for mission‑critical enterprise AI. Founder Andrew Moore says the system can answer investigative queries using only one‑thousandth the tokens of conventional models, targeting sectors where...
FDA Approves Otarmeni, First Gene Therapy for Genetic Hearing Loss
The U.S. Food and Drug Administration authorized Otarmeni, the first dual‑AAV gene therapy for OTOF‑associated severe-to-profound hearing loss, after a 61‑day accelerated review. The approval opens a new therapeutic pathway for patients whose condition has previously been managed only with...
Biogen Inc (BIIB) Q1 2026 Earnings Call Transcript
Biogen reported $2.8 billion revenue for Q1 2026, a 7% increase driven by four new launch products and resilient U.S. multiple‑sclerosis sales. Non‑GAAP diluted EPS rose 4% to $5.25, and the company lifted its 2025 EPS guidance to $15.50‑$16 while keeping revenue...
Acadia Healthcare Company Inc (ACHC) Q1 2026 Earnings Call Transcript
Acadia Healthcare reported Q3 2025 revenue of $851.6 million, a 4.4% year‑over‑year increase, but adjusted EBITDA slipped to $173 million, $5 million below internal forecasts. The company lowered its full‑year outlook, trimming revenue to $3.28‑$3.30 billion and adjusted EBITDA to $650‑$660 million....
Improving Access to Essential Medicines via Decision-Aware Machine Learning
A new wave of decision‑aware machine‑learning models is being applied to pharmaceutical supply chains in low‑income regions, blending demand forecasts with inventory and distribution constraints. Early pilots in Zambia and Rwanda report up to a 30% reduction in stock‑outs and...
Amarin Corporation PLC (AMRN) Q1 2026 Earnings Call Transcript
Amarin Corporation reported first‑quarter 2024 net revenue of $56.5 million, down from $86 million a year earlier, as U.S. sales fell amid generic competition. The company secured an extended European patent runway for VASCEPA through 2039, reinforcing its market position. European commercial...
Agios Pharmaceuticals Inc (AGIO) Q1 2026 Earnings Call Transcript
Agios Pharmaceuticals reported a 45% year‑over‑year jump in PYRUKYND net revenue to $12.5 million, driven by stronger PKD sales, an extra ordering week, and higher specialty‑pharmacy processing. The company ends the quarter with roughly $1.3 billion in cash, supporting both commercial rollout...
GE Healthcare Technologies Inc (GEHC) Q1 2026 Earnings Call Transcript
GE Healthcare Technologies reported Q1 2026 revenue of $5.7 billion, up 4.8% organically, and posted a record $21.8 billion backlog with a book‑to‑bill ratio above 1. Adjusted EBIT margin fell to 16.7% due to roughly $100 million in tariff expenses and an unfavorable...
Safety and Efficacy of Intratumoural Anti-CTLA4 with Intravenous Anti-PD1
The phase 1b NIVIPIT trial compared intratumoural (IT) ipilimumab at 0.3 mg kg⁻¹ plus intravenous nivolumab with the standard intravenous (IV) ipilimumab‑nivolumab regimen in untreated advanced melanoma. The IT arm achieved a markedly lower rate of grade 3‑4 treatment‑related adverse events (24 % vs 67 %...
Ionis Pharmaceuticals Inc (IONS) Q1 2026 Earnings Call Transcript
Ionis Pharmaceuticals reported record 2025 revenue of $944 million, a 34% year‑over‑year increase driven by strong sales of TRYNGOLZA, the launch of DAWNZERA, and robust R&D collaboration fees. Phase III data for olezarsen demonstrated up to a 72% reduction in triglycerides and...
Conmed Corp (CNMD) Q1 2026 Earnings Call Transcript
Conmed Corp reported Q1 2026 results with total sales of $373.2 million, a 7.9% year‑over‑year increase, and full‑year revenue of $1.375 billion, up 5.2%. Orthopedic sales led growth, rising 12.1% in the quarter and 5.5% for the year, while international sales surged...
Urban Edge Properties (UE) Q1 2026 Earnings Call Transcript
Urban Edge Properties reported Q1 2026 net revenue of $12.5 million, a 45% year‑over‑year increase driven by stronger PKD sales, an extra ordering week, and expanded specialty pharmacy distribution. Patient enrollment rose to 248 completed forms with 142 patients now on...
Regeneron Pharmaceuticals Inc (REGN) Q1 2026 Earnings Call Transcript
Regeneron reported Q1 2025 revenue of $3 billion, with Dupixent and Libtayo delivering double‑digit growth while U.S. EYLEA sales fell 39% to $736 million amid co‑pay assistance gaps and rising Avastin use. Gross margin guidance was revised to 86‑87% after larger‑than‑expected inventory...
Anika Therapeutics Inc (ANIK) Q1 2026 Earnings Call Transcript
Anika Therapeutics posted total revenue of $28.2 million for the quarter, an 8% decline driven by manufacturing yield issues and a $900,000 shortfall in international osteoarthritis‑pain sales. Gross margin fell to 51%—down 16 percentage points—after a one‑time $3 million non‑cash charge, though...
AbbVie Inc (ABBV) Q1 2026 Earnings Call Transcript
AbbVie reported Q1 2024 revenue of $12.3 billion and adjusted earnings per share of $2.31, both topping internal forecasts. The company highlighted more than 15% growth from its post‑Humira portfolio, driven by double‑digit gains in Skyrizi, Rinvoq, Venclexta and other assets....
CDC Confirms Rare Imported Case of Measles From Japan in 7 Years
The Taiwan Centers for Disease Control confirmed a measles case in a 30‑year‑old Taiwanese man who returned from Japan, marking the first imported case from that country in seven years. Japan has reported a surge to 299 measles cases this...
Boosting T Helper Cells Could Curb Lifelong Viral Infections
The immune system actively combats lifelong viral infections acquired at birth, but its response is limited by a reduced pool of T helper cells; enhancing these cells may offer new therapeutic strategies. immunology
Psychedelics for Mental Illness: Dr. Joseph Varon on Trump’s Executive Order
In this episode, Fox News discusses President Trump's new executive order aimed at loosening restrictions and expanding access to psychedelic therapies for severe mental health conditions such as depression, PTSD, and addiction, especially among veterans. Dr. Joseph Varon, president and...
Cancer Is Increasing in Young People and We Still Don't Know Why
Recent research shows colorectal cancer among young adults is climbing sharply, with a 50% increase since the 1990s in several high‑income nations. A UK study identified 11 cancer types rising in people aged 20‑49, attributing only a small share of...
UConn Health Signs Letter of Intent for 2 Hospitals
UConn Health announced a letter of intent to bring Day Kimball Hospital and Bristol Health into its network, extending the academic medical center’s reach in Connecticut. The move follows UConn Health’s March acquisition of Waterbury Hospital from the bankrupt Prospect...
How Tech Can Bridge Gaps in Rural Healthcare Data Struggles
The Office of the National Coordinator for Health IT is pushing technology to cut costs and improve care in rural America. A new ONC mandate requires electronic health records to show prescription benefit information, giving patients price transparency at the...
UTHealth Houston Names Business Affairs, Strategy Chief
UTHealth Houston announced the appointment of Michael Patriarca as executive vice president and chief business affairs and strategy officer. The newly created role is designed to steer long‑range strategic planning while overseeing finance, operations, IT, data analytics, and infrastructure. Patriarca...
NVO’s 4.4% Yield Boosted by Oral Semaglutide Surge
$NVO pays a decent 4.4% dividend and oral semaglutide is surging: "First-time anti-obesity medication (AOM) prescribing increased 21.7% from December 2025 to March 2026, with first-time AOM semaglutide prescribing increasing by more than 50%. AOM semaglutide also showed its largest quarter-over-quarter percentage...
Nicotinamide Boosts NK Cells, Induces NHL Remissions
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma https://t.co/VrC2ertsVd